Dublin, Oct. 19, 2016 -- Research and Markets has announced the addition of the "IV Fluid Transfer Drugs Devices and Markets" report to their offering.
Intravenous drug administration is one of the most common therapeutic procedures that patients in a hospital setting are likely to receive. Yet the lack of standardization among the various components, elements and steps that a caregiver must navigate to successfully execute a drug infusion have - according to several recent studies - contributed to medication errors and risks to patient safety.
IV drug administration was once provided to patients only in clinical settings. However, technology developments and a greater emphasis on cost containment over the last 30 years have prompted a shift to providing this therapy in alternate settings, including the home. IV fluid transfer drugs devices and markets is a detailed analysis of this evolving market.
What You Will Learn
- Analyzes and evaluates the global market for IV fluid transfer devices and assesses the probable impact of evolving regulatory, economic and demand factors
- Assesses approved IV fluid transfer devices and their market position
- Provides detailed descriptions of IV fluid transfer market segments and market factors
- Profiles sector companies, their product development activities, supply chain partners, business strategies, and collaboration partners
- Evaluates the impact of economic, technology, and regulatory factors on IV drug administration
Key Topics Covered:
1. Executive Summary
2. IV Administration Market Dynamics
- Evolution in Patient Care
- Demand Drivers
- Competitive Landscape
- Factors Limiting Growth
3. IV Fluid Transfer Device Design Factors
- Reducing Medication Errors
- Lyophilization and Reconstitution
- Provider and Patient Wellbeing
4. Device Profiles and Analysis
- I.V. Containers
- Fluid Transfer Devices
- Reconstitution Devices
5. Market Analysis and Assessment
- Autoimmune
- Blood Disorders
- Cardiovascular
- Metabolic
- Neurology
- Oncology
6. Market Factors
- Regulatory Factors
- Managed Care Initiatives
7. Product Evolution and Wearable Infusion Devices
8. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/cnbzjg/iv_fluid_transfer
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infusions and Injectables


Washington Post Publisher Will Lewis Steps Down After Layoffs
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



